|
Kubota, S; Copeland, T D; Pomerantz, R J (1999) Nuclear and nucleolar targeting of human ribosomal protein S25: common features shared with HIV-1 regulatory proteins. Oncogene 18:1503-14
|
|
Jiang, A; Fisher, H; Pomerantz, R J et al. (1999) A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide. Hum Gene Ther 10:2627-36
|
|
Kubota, S; Pomerantz, R J (1998) A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins. Oncogene 16:1851-61
|
|
Ho, W Z; Lai, J P; Bouhamdan, M et al. (1998) Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments. AIDS Res Hum Retroviruses 14:1573-80
|
|
Inouye, R T; Du, B; Boldt-Houle, D et al. (1997) Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector. J Virol 71:4071-8
|
|
Duan, L; Zhu, M; Ozaki, I et al. (1997) Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy. Gene Ther 4:533-43
|
|
Pilkington, G R; Duan, L; Zhu, M et al. (1996) Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a combinatorial phage display library. Mol Immunol 33:439-50
|
|
Zhu, M; Duan, L; Pomerantz, R J (1996) TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells. AIDS Res Hum Retroviruses 12:1093-101
|
|
Levy-Mintz, P; Duan, L; Zhang, H et al. (1996) Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol 70:8821-32
|
|
Mukhtar, M; Duan, L; Bagasra, O et al. (1996) Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Gene Ther 3:725-30
|
Showing the most recent 10 out of 20 publications
